Cargando...
Insight into next-generation CAR therapeutics: designing CAR T cells to improve clinical outcomes
Chimeric antigen receptor (CAR) T cell therapy has shown considerable promise for hematologic malignancies, leading to the US Food and Drug Administration approval of two CAR T cell–based therapies for the treatment of B cell acute lymphoblastic leukemia and large B cell lymphoma. Despite success in...
Guardado en:
| Publicado en: | J Clin Invest |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Clinical Investigation
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7810492/ https://ncbi.nlm.nih.gov/pubmed/33463538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI142030 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|